Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1308
Selected: 0
NCT IDTitle
NCT01924520Oral Multiple-dose Study in Patients With Major Depressive Disorder
NCT03941483Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
NCT00413218Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
NCT04076059An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
NCT01187186A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941
NCT06150820A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
NCT06364696A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
NCT02274779Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer
NCT01655043Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI
NCT02747017Observational Study of C. Diff in Post-Transplant Patients
NCT05169372Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From Brazil
NCT01635946Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin
NCT01126424A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability
NCT02358096A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease
NCT00936078The Living Kidney Donor Safety Study
NCT02136706Feasibility and Diagnostic Accuracy of Myocardial SPECT Using Early Imaging Protocol
NCT02147938A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)
NCT01535547Drug Interaction Study of Isavuconazole and Tacrolimus
NCT04076943Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia
NCT01115985A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers
NCT00902291A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
NCT01499654Half-Dose Radiopharmaceutical in Wide Beam Reconstruction
NCT03528629A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
NCT00892749Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
NCT03753243Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
NCT01697995Stress Induced Right Ventricular Uptake on Lexiscan Stress MPI
NCT01279538A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Transplantation
NCT07734064A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
NCT03246347A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer
NCT04476849A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function
NCT07488676A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
NCT00832585Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis
NCT02528643A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma
NCT01478607A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients
NCT03565445A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors
NCT01070901Immune Status in Solid Organ Transplantation
NCT00662909A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
NCT02794792A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
NCT00985387Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients
NCT00643071Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients
NCT01672736A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
NCT02288936Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer
NCT03177187Combination Study of AZD5069 and Enzalutamide.
NCT03182244A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
NCT03403790A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
NCT03572231A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
NCT00901251Reproducibility Study of Over Active Bladder Symptom Score [OABSS]
NCT01114230A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer
NCT03653507A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT02052375A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate